Follows D, Tiberg F, Thomas R K, Larsson M
Physical and Theoretical Chemistry Laboratory, South Parks Road, Oxford, OX1 3QZ, UK.
Biochim Biophys Acta. 2007 Feb;1768(2):228-35. doi: 10.1016/j.bbamem.2006.10.004. Epub 2006 Oct 18.
Pharmacy-grade exogenous lung surfactant preparations of bovine and porcine origin, dispersed in physiological electrolyte solution have been studied. The organization and dynamics at the air/water interface at physiological temperature was analysed by neutron reflection. The results show that a well-defined surface phase is formed, consisting of a multilayer structure of lipid/protein bilayers alternating with aqueous layers, with a repetition period of about 70 A and correlation depths of 3 to >25 bilayers, depending on electrolyte composition and time. The experimental surfactant concentration of 0.15% (w/w) is far below that used in therapeutic application of exogenous surfactants and it is therefore likely that similar multilayer structures are also formed at the alveolar surface in the clinical situation during surfactant substitution therapy. Lung surfactant preparations in dry form swell in aqueous solution towards a limit of about 60% (w/w) of water, forming a lamellar liquid-crystalline phase above about 34 degrees C, which disperses into lamellar bodies at higher water concentrations. The lamellar spacings in the surface multilayers at the air/water interface are smaller than those in the saturated limit even though they are in contact with much greater water concentrations. The surface multilayers are laterally disordered in a way that is consistent with fragments of Lalpha-phase lamellae. The near surface layers of the multilayer structure have a significant protein content (only SP-B and SP-C are present in the preparations). The results demonstrate that a multilayer structure can be formed in exogenous surfactant even at very low concentrations and indicate that multilayers need to be incorporated into present interpretations of in vitro studies of similar lung surfactant preparations, which are largely based on monolayer models.
对源自牛和猪的药用级外源性肺表面活性剂制剂进行了研究,这些制剂分散于生理电解质溶液中。通过中子反射分析了生理温度下空气/水界面处的组织结构和动力学。结果表明,形成了一个明确的表面相,由脂质/蛋白质双层与水层交替的多层结构组成,重复周期约为70埃,相关深度为3至超过25个双层,这取决于电解质组成和时间。实验中的表面活性剂浓度为0.15%(w/w),远低于外源性表面活性剂治疗应用中的浓度,因此在表面活性剂替代治疗的临床情况下,肺泡表面可能也会形成类似的多层结构。干燥形式的肺表面活性剂制剂在水溶液中膨胀至约60%(w/w)的水极限,在约34摄氏度以上形成层状液晶相,在更高的水浓度下分散成层状体。尽管空气/水界面处表面多层中的层间距与水浓度更高的饱和极限处的层间距接触,但前者更小。表面多层在横向无序,其方式与Lα相薄片的片段一致。多层结构的近表面层含有大量蛋白质(制剂中仅存在表面活性蛋白B和表面活性蛋白C)。结果表明,即使在非常低的浓度下,外源性表面活性剂也能形成多层结构,并表明多层结构需要纳入目前对类似肺表面活性剂制剂体外研究的解释中,这些研究主要基于单层模型。